Anuh Pharma Ltd.
Fundamentals
- Market cap
- ₹761 cr
- P/E
- 18.56×
- ROE
- 14.52%
- Debt / equity
- 0.03
- Div yield
- 1.97%
- 52-week range
- 66.72 — 115.00
The timeline — 4 notes on Anuh Pharma Ltd.
May 2026
- 21 May 26 · 12:53 IST Brief Brief · Earnings
Anuh Pharma's FY26 revenue rose 16.6% but profit fell 13.3%
The divergence between topline growth and bottomline decline is the standout signal in an otherwise routine annual results filing. Dividend recommended at ₹1.50 per share.
- 20 May 26 · 23:56 IST Brief Brief · Earnings
Anuh Pharma revenue up 16%, but profit slips 13% in FY26
Top-line growth couldn't protect margins: PAT fell to ₹41.05 cr despite a ₹771.66 cr top line.
- 20 May 26 · 22:52 IST Brief Brief · Earnings
Anuh Pharma's profit slipped 13% even as revenue rose 17% in FY26
The ₹771 cr pharma company saw a margin squeeze; board recommends ₹1.50 dividend.
- 20 May 26 · 21:58 IST Brief Brief · Earnings
Anuh Pharma's profit slipped 13% despite 16.6% revenue growth
Revenue rose to ₹771.66 cr but PAT fell to ₹41.05 cr; board recommends ₹1.50/sh dividend.